These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 282940
21. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity. Abe I, Saito S, Hori K, Suzuki M, Sato H. Cancer Res; 1982 Jul; 42(7):2846-51. PubMed ID: 7083175 [Abstract] [Full Text] [Related]
22. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology. Early AP, Preisler HD, Slocum H, Rustum YM. Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642 [Abstract] [Full Text] [Related]
23. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells. Yamauchi T, Negoro E, Kishi S, Takagi K, Yoshida A, Urasaki Y, Iwasaki H, Ueda T. Biochem Pharmacol; 2009 Jun 15; 77(12):1780-6. PubMed ID: 19428333 [Abstract] [Full Text] [Related]
24. Saturation of ara-CTP accumulation during high-dose ara-C therapy: pharmacologic rationale for intermediate-dose ara-C. Plunkett W, Liliemark JO, Estey E, Keating MJ. Semin Oncol; 1987 Jun 15; 14(2 Suppl 1):159-66. PubMed ID: 3589690 [No Abstract] [Full Text] [Related]
25. Dephosphorylation of nucleotides of 1-beta-D-arabinofuranosylcytosine in relation to the different drug sensitivity in tumor cells. Abe I, Sato H. Tohoku J Exp Med; 1979 Mar 15; 127(3):281-8. PubMed ID: 442078 [No Abstract] [Full Text] [Related]
26. Multiple determinants of antimetabolite action in humans. Rustum YM. Bull Cancer; 1979 Mar 15; 66(1):93-6. PubMed ID: 283838 [No Abstract] [Full Text] [Related]
27. Ara-CTP metabolism following hydroxyurea or methotrexate treatment in human leukemia cell lines. Kubota M, Takimoto T, Kitoh T, Tanizawa A, Akiyama Y, Kiriyama Y, Mikawa H. Adv Exp Med Biol; 1989 Mar 15; 253B():363-7. PubMed ID: 2610124 [No Abstract] [Full Text] [Related]
30. Altered sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate of DNA polymerase alpha from leukemic blasts of acute lymphoblastic leukemia. TAnaka M, Yoshida S. Cancer Res; 1982 Feb 15; 42(2):649-53. PubMed ID: 6948608 [Abstract] [Full Text] [Related]
35. Effects of tetrahydrouridine on the uptake and metabolism of 1-beta-D-arabinofuranosylcytosine in human normal and leukemic cells. Ho DH, Carter CJ, Brown NS, Hester J, McCredie K, Benjamin RS, Freireich EJ, Bodey GP. Cancer Res; 1980 Jul 15; 40(7):2444-6. PubMed ID: 6248205 [No Abstract] [Full Text] [Related]
36. Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias. Karp JE, Passaniti A, Gojo I, Kaufmann S, Bible K, Garimella TS, Greer J, Briel J, Smith BD, Gore SD, Tidwell ML, Ross DD, Wright JJ, Colevas AD, Bauer KS. Clin Cancer Res; 2005 Dec 01; 11(23):8403-12. PubMed ID: 16322302 [Abstract] [Full Text] [Related]
37. Correlation of drug-perturbed marrow cell growth kinetics and intracellular 1-B-D-arabinofuranosylcytosine metabolism with clinical response in adult acute myelogenous leukemia. Karp JE, Donehower RC, Dole GB, Burke PJ. Blood; 1987 Apr 01; 69(4):1134-40. PubMed ID: 3470054 [Abstract] [Full Text] [Related]
38. Simultaneous determination of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 3-deazauridine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography. Plunkett W, Chubb S, Barlogie B. J Chromatogr; 1980 Dec 12; 221(2):425-30. PubMed ID: 6938519 [No Abstract] [Full Text] [Related]
39. [Letter: New combination drug therapy of acute myeloid leukemia]. Fière D, Bryon PA, Martin C, Péaud PY. Nouv Presse Med; 1975 Sep 13; 4(29):2114 (1). PubMed ID: 1058467 [No Abstract] [Full Text] [Related]